Rare diseases
Investigational molecules
Locations
Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands
Stichting Radboud University Medical Center in Nijmegen, The Netherlands specialises in clinical trials of conditions such as Crohn's disease, Non-small cell lung cancer, Colitis ulcerative, Arteriosclerosis, and other specialisations. This site conducts important research.
The Medical Oncology department in Nijmegen is conducting clinical trials in oncology focused on improving care for patients with advanced cancers, especially ovarian cancer and metastatic castration-resistant prostate cancer. These studies are designed to evaluate whether new treatment combinations can extend survival and delay disease progression.
This research reflects a strong focus on personalized cancer treatment and on finding better options for patients with difficult-to-treat malignancies.
At Stichting Radboud University Medical Center, trials in ophthalmology are exploring better ways to support recovery after corneal transplantation, including Descemet's Membrane Endothelial Keratoplasty (DMEK). The main goal is to improve transplant success while reducing complications and protecting eye health over the long term.
This area of research aims to make eye transplant care safer and more effective for patients with corneal disease.
Clinical trials in reproductive health are examining causes and treatments for unexplained recurrent miscarriages. The research is focused on whether a medicine used early in pregnancy can improve the chance of a live birth for women facing repeated pregnancy loss.
These studies aim to generate clearer evidence for managing a challenging condition in maternal and fetal medicine.
More sites in NijmegenThe Netherlands
Clinical trials currently enrolling participants at this site.
The NetherlandsStudy of lunsekimig versus placebo in adults with inadequately controlled eosinophilic COPD
The NetherlandsA Phase 3 Randomized Study of mRNA‑4157 plus Pembrolizumab as Adjuvant Therapy in Patients with Completely Resected Stage I Non‑Small Cell Lung Cancer
The NetherlandsA Phase III Study of Survodutide in Adults with Compensated NASH Cirrhosis to Assess Liver Outcomes and Safety
The NetherlandsA Phase III trial of BI 456906 weekly injections in adults with NASH and stage 2‑3 liver fibrosis
The NetherlandsA study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
The NetherlandsA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
The NetherlandsA Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis
The NetherlandsA study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy
The NetherlandsA study testing duvakitug for patients with moderately to severely active ulcerative colitis
The NetherlandsStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
The NetherlandsStudy of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease
The NetherlandsMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
